TrIP-2SS + formoterol

TrIP-2SS + formoterol is a combination drug consisting of two active components: - **TrIP-2SS** (no publicly available information found; likely an investigational or experimental agent with no established clinical use or published mechanism as of May 2025) - **Formoterol**, a long-acting beta2-adrenergic receptor agonist (LABA), is used as a bronchodilator in the management of asthma and chronic obstructive pulmonary disease (COPD). Formoterol acts on bronchial smooth muscle to induce relaxation and dilation of airways, providing both rapid onset and prolonged duration of action[6]. The combination would theoretically pair the pharmacological effects/mechanism(s) of TrIP-2SS with those of formoterol. However, there are no approved products or clinical trial data for this specific combination in public sources as of May 2025.